Skip to main content

Month: August 2021

W. R. Grace Holdings LLC Commences Exchange Offers

W. R. Grace & Co.-Conn. Commences Consent Solicitations NEW YORK, Aug. 03, 2021 (GLOBE NEWSWIRE) — W. R. Grace Holdings LLC (formerly known as Gibraltar Acquisition Holdings LLC) (“Holdings”) and W. R. Grace & Co. (NYSE: GRA) (“Grace”) today announced that, in connection with the anticipated combination of Holdings and Grace, Holdings has commenced offers to eligible holders to exchange (each an “Exchange Offer” and collectively, the “Exchange Offers”) any and all outstanding notes issued by W. R. Grace & Co.-Conn. (the “Grace Issuer”) as set forth in the table below (the “Existing Grace Notes”) for (1) up to $1,050,000,000 aggregate principal amount of new notes issued by Holdings (the “New Secured Notes”) and (2) cash. The following table sets forth the Exchange Consideration, Early Tender Premium and Total Exchange...

Continue reading

Helios Fairfax Appoints Masai Ujiri to Its Board of Directors

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) — Helios Fairfax Partners Corporation (“Helios Fairfax”) (TSX:HFPC.U) announces that it has appointed Masai Ujiri as an independent director. Ujiri grew up in Zaria, Nigeria, attended college in the United States, and became the first African general manager in professional sports in 2011, while with the Denver Nuggets. In 2013, he was named Executive of the Year. Under Ujiri’s leadership, in 2019 the Toronto Raptors became the first team outside the United States to win an NBA Championship. In 2003, Ujiri co-founded Giants of Africa, an organization which uses sports as a tool to enrich the lives of youth on the continent. The organization’s ethos is “Dream Big,” and Giants now connects with youth – boys...

Continue reading

Daseke Reports Record Results for Second Quarter of 2021 and Raises 2021 Outlook

Strong operational execution and improving demand combine to drive record quarterly Operating Ratio and Adjusted EBITDA ADDISON, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), the largest flatbed, specialized transportation and logistics solutions company in North America, today reported financial results for the quarter ended June 30, 2021. Second Quarter 2021 Highlights:Revenue of $404.0 million Net income of $35.3 million, or $0.49 per diluted share attributable to common stockholders, compared to $1.6 million in last year’s second quarter Record Adjusted Net Income ex-Aveda of $30.2 million, or $0.42 per diluted share attributable to common stockholders Record Adjusted EBITDA of $69.2 millionResults up 20% compared to prior quarterly record of $57.6 million in Q3 2020Cash...

Continue reading

Correction: TGS Vesting Under the 2018 Long-term Incentive Plan

In accordance with the measures approved by the shareholders of TGS at the Annual General Meeting on 8 May 2018, the Board of Directors of TGS ASA authorized TGS to grant Performance Stock Units (PSUs), Performance Restricted Stock Units (P-RSUs), and Restricted Stock Units (RSUs) under the 2018 Long Term Incentive Plan to key employees of TGS on 3 August 2018.  Each RSU represented the right to receive one share, while each PSU and P-RSU represented the right to receive a maximum of one share depending on performance against target metrics during the measurement period of 1 January 2018 to 31 December 2020.  The granted PSUs, P-RSUs, and RSUs were secured by free-standing warrants. In accordance with the terms of the 2018 Long Term Incentive Plan, the PSUs, P-RSUs, and RSUs vested on 3 August 2021, resulting in a total of 58 PSU/P-RSU/RSU...

Continue reading

Juggernaut Commences Drilling of Two Extensive High-Grade Gold-Silver Targets in Northwest B.C.

VANCOUVER, British Columbia, Aug. 03, 2021 (GLOBE NEWSWIRE) — Juggernaut Exploration Ltd. (TSX-V: JUGR) (OTCQB: JUGRF) (FSE: 4JE) (the “Company” or “Juggernaut”) is pleased to report it has commenced inaugural diamond drill programs at each of its 100% controlled GoldStandard and Goldstar projects. Drilling is designed to test newly discovered extensive high-grade gold-silver zones to depth. These projects are situated in the prolific mineralized terrain of northwestern British Columbia and are located in close proximity to infrastructure providing for cost effective exploration. GOLDSTANDARD PROPERTY: GOLDZILLA HINGE ZONE DRILL TARGET #1 100m long by up to 20m wide Hinge Zone containing high grade gold mineralization of up to 6.00 g/t AuEq over 12m including 5m of 13.03 g/t AuEq and 1m of 31.66 AuEq (schematic of hinge zone)....

Continue reading

A Constructive First Meeting Between GSLR and Canada Carbon

GRENVILLE-SUR-LA-ROUGE, Quebec, Aug. 03, 2021 (GLOBE NEWSWIRE) — Canada Carbon Inc. (“the Company” or “Canada Carbon” or “CCB”) (TSX-V:CCB), (FF:U7N1), and the Municipality of Grenville-sur-la-Rouge (“GSLR”) are pleased to announce that they held a meeting on July 27, 2021 to begin a meaningful dialogue. Virtually all previous interactions between the parties were limited to correspondence via emails and letters and can be found on the Miller Project website in the Document Library under the Agreement with GSLR tab.   In its notification of a change in preliminary orientation, La Commission de Protection du territoire Agricole du Quebec (“CPTAQ”) indicated that additional information was required from Canada Carbon in order for its zoning change application to be appropriately reviewed. The additional data that Canada Carbon plans...

Continue reading

Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced today that medac, Medexus’ licensor for treosulfan, has received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) in response to its New Drug Application (NDA) for treosulfan. As previously disclosed, the NDA was submitted for use of treosulfan in combination with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT), and both Medexus and medac had been optimistic that a positive decision from the FDA in connection with a planned Prescription Drug User Fee Act (“PDUFA”) date on August 11th would allow for a commercial launch of treosulfan in U.S. later this year. However,...

Continue reading

EbixCash Announces Appointment of Eminent Career Banker – Sunil Srivastav to Its Board of Directors

NOIDA, India and JOHNS CREEK, Ga., Aug. 03, 2021 (GLOBE NEWSWIRE) — EbixCash Private Limited, a subsidiary of Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries today announced the appointment of Mr. Sunil Srivastav, as a new independent director to the EbixCash Board. Sunil is a career banker, having retired as Deputy Managing Director of the Corporate Accounts Group at India’s largest bank – State Bank of India (SBI), after serving the bank for 38 years. Sunil brings a vast repertoire of experience across the international banking sector having spent a major part of his career in corporate banking at SBI, investment banking at SBI Capital Markets Ltd., besides a 5 year stint at SBI’s New York office. Sunil...

Continue reading

Atlantica Reports Second Quarter 2021 Financial Results

Revenue for the first half of 2021 increased by 31.2% year-over-year up to $611.2 million, and an increase of 13.5% year-over-year on a comparable basis1. Adjusted EBITDA including unconsolidated affiliates was $404.2 million in the first half of 2021, a 6.3% year-over-year increase. Net loss for the first half of 2021 attributable to the Company was $6.8 million, compared with a net loss of $28.2 million in the first half of 2020. Cash available for distribution (“CAFD”) increased by 12.9% year-over-year up to $109.9 million in the first half of 2021. $400 million in Green Senior Notes successfully closed in May, extending part of our corporate debt maturity from 2025 to 2028. Closed the previously announced investments in Coso, a 135 MW contracted renewable energy plant in California, and a 49% interest in a 596 MW portfolio of wind...

Continue reading

Tauriga Sciences Inc. Confirms That It’s on Pace for a Strong Quarter From Its Retail Business

The Company’s Current Operating Quarter is Its 2nd Fiscal Quarter 2022 (Period: July 1, 2021 – September 30, 2021) NEW YORK, NY, Aug. 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, has today confirmed that it’s on pace for a strong Quarter from its retail business.  The Company’s current operating Quarter is its 2nd Fiscal Quarter 2022 (Period: July 1, 2021 – September 30, 2021). During the month of July 2021, the Company has experienced acceleration in both demand and interest, for its enhanced products and product lines as well as its innovative, newly introduced, product offerings.  The Company has also been successful in integrating cost saving measures into its manufacturing processes, without even...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.